SARS-CoV-2 infection in severe pediatric Crohn's disease. What about anti-tumor necrosis factor α therapy?

We report the case of a 17 years-old female patient, affected by COVID-19 and under anti-TNF α treatment with adalimumab for severe Crohn's disease. She was diagnosed 10 years ago with a severe ileal and perianal complex

Source: Digestive and Liver Disease - July 10, 2020 Category: Gastroenterology Authors: Bardasi Giulia, Alvisi Patrizia Tags: Correspondence Source Type: research